Thursday, 16 March 2017

French biotech firm closes in on cancer that killed Steve Jobs

LONDON (Reuters) - A French biotech firm is hoping to gain approval within months for a nuclear medicine targeting the type of cancer that killed Steve Jobs.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)